While precision oncology requires robust biomarkers, current predictors for lung adenocarcinoma (LUAD) often show limited clinical utility. This study investigates the multifaceted roles of ZC3H12D, a ...

I never thought in a million years that this would happen to me … especially so young,” Brooklynite Jaclyn Keely told The ...

A recent study has uncovered an unexpected connection between our diets and the progression of lung cancer, specifically a ...

Lung cancer is a leading cause of cancer deaths around the world, and is often not diagnosed until it is in late stages that are frequently untreatable... | Cell And Molecular Biology ...

Ariel Lopez-Chavez, MD, medical oncologist, director of precision medicine and developmental therapeutics at Allegheny Health Network Cancer Institute, discusses comprehensive genomic profiling and ...

Belrestotug showed underwhelming efficacy outcomes in mid-stage studies of non-small cell lung cancer and head and neck ...

Janux Therapeutics, Inc.’s JANX share price has dipped by 7.22%, which has investors questioning if this is right time to buy ...

GSK and iTeos are the latest companies to scrap a jointly developed anti-TIGIT drug after it failed to demonstrate a ...

Amanda Pair Foundation, established in honor of Amanda Pair who died after a cancer diagnosis, is aimed at helping people ...

The latecomer PD-1 inhibitor – already approved for Merkel cell carcinoma – has become the first cancer immunotherapy for ...